GlassScriptPhysician profile
Ahsan M Hamid
NPI 1598187767
$4,655.02
in general payments reported to CMS, 2019-2025
17 companies · $375 in 2025
The $375 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $746 · 2022: $1,076 · 2023: $1,678 · 2024: $780 · 2025: $375.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,784 · Education: $48.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,784.28 |
| Education | $48.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,702.46 | 2021-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $971.31 | 2021-2025 | Caplyta |
| Alkermes, INC. | $701.26 | 2021-2023 | Lybalvi, Aristada, Aristada Initio |
| Corium, LLC | $352.98 | 2021-2024 | Azstarys |
| Sunovion Pharmaceuticals INC. | $204.93 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $167.90 | 2023-2024 | Spravato |
| Tris Pharma INC | $84.28 | 2022-2023 | Dyanavel Xr |
| Otsuka America Pharmaceutical, INC. | $82.64 | 2021-2023 | Rexulti |
| Axsome Therapeutics, INC. | $80.26 | 2023 | Auvelity |
| Takeda Pharmaceuticals U.S.A., INC. | $47.68 | 2022 | |
| Lundbeck LLC | $46.20 | 2023-2024 | Rexulti |
| Idorsia Pharmaceuticals US INC | $44.74 | 2023 | Quviviq |
| Ironshore Pharmaceuticals INC. | $41.29 | 2022-2023 | Jornay Pm |
| Neurocrine Biosciences, INC. | $38.76 | 2024-2025 | Ingrezza |
| E.R. Squibb & Sons, L.L.C. | $36.88 | 2025 | Cobenfy |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vanda Pharmaceuticals INC. | $26.67 | 2025 | Fanapt |
| Pulmonx Corporation | $24.78 | 2025 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Chartis Catheter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ahsan Hamid listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.